Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NIH × BNT162 Vaccine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

human papillomavirus vaccine, L1 type 16, 18 2 adacel 2 Tetanus Toxoid 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Diphtheria-Tetanus-acellular Pertussis Vaccines 2 Diphtheria Toxoid 2 testosterone enanthate 1 sofosbuvir-velpatasvir drug combination 1 pegfilgrastim 1 fluarix 1 epoetin beta 1 arexvy 1 abrysvo 1 Vincristine 1 Thyrotropin Alfa 1 Radiotherapy 1 Oxycodone 1 Oxaliplatin 1 Morphine 1 Levopropoxyphene 1 Influenza Vaccines 1 Heplisav-B 1 FluLaval 1 Filgrastim 1 Etanercept 1 Epoetin Alfa 1 Dutasteride 1 Dactinomycin 1 Craniotomy 1 Codeine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡